Search results
15 paź 2022 · Although the cost of HPV DNA testing is one of the barriers of cervical cancer screening, especially in the LMICs, the cost of the assay used in this investigation is similar to the general HPV RT-PCR assays available in the Nigerian market.
22 kwi 2020 · However, high-risk HPV (HR-HPV) counts was higher among groups with HIV infections (n = 43) compared to the HIV-negative group. Additionally, Hr-HPV infection was significantly high (27/86 = 31%) in HIV-positive women compared to HIV-negative women (20/86 = 23%).
28 mar 2024 · Testing scale-up and sensitization efforts across health facilities, including cervical tissue sample collection, are needed to reduce the cases of cervical cancer. This study aimed to assess the genotype-specific prevalence of clinically relevant high-risk HPV among women living with HIV in Nigeria. Methods.
3 maj 2023 · This study investigated the willingness to pay for HPV vaccination among WLWH in Nigeria. Cervical cancer remains a significant public health concern in Nigeria. However, it is clear that HPV awareness is low, and specific knowledge was generally poor among WLWH in Nigeria.
5 lis 2013 · We enrolled women presenting at our cervical cancer screening program in Abuja, Nigeria between April and August 2012, and collected information on demographic characteristics, risk factors of HPV infection and samples of exfoliated cervical cells.
I. Key data on HPV and HPV-related cancers. Nigeria has a population of Figure 1. Comparison of the ten most frequent HPV 60.9 million women ages 15 oncogenic types in Nigeria among women with and years and older who are at risk without cervical lesions. of developing cervical cancer.
2 lip 2024 · Conclusion: This study showed high prevalence of HPV infections among HIV-infected patients on ART in Plateau State, north-central Nigeria including detection of high-risk HPV types 16 and 18, which are major risk factors for progression of cervical intraepithelial neoplasia to cervical cancer.
